BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis

被引：34
|
作者：
Schultheis, B [1 ]
Wang, L
Clark, RE
Melo, JV
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, London, England
[2] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
来源：
LEUKEMIA | 2003年 / 17卷 / 10期
关键词：
D O I：
10.1038/sj.leu.2403079
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2054 / 2055
页数：3
相关论文
共 50 条
  • [41] Rapid response to Dasatinib in a CML blast crisis patient that subsequently developed sequential Bcr-Abl mutations causing multi-drug resistance: A case report
    Stagno, F.
    Stella, S.
    Berretta, S.
    Massimino, M.
    Antolino, A.
    Vigneri, P.
    Di Raimondo, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 181 - 181
  • [42] Molecular responses to tyrosine kinase inhibitors in rare, variant e1a2, e6a2 and e19a2 BCR-ABL chronic myeloid leukaemia
    Langabeer, S. E.
    Crampe, M.
    McCarron, S. L.
    Haslam, K.
    Connaghan, G.
    Perera, K.
    Cahill, M. R.
    Conneally, E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 74 - 74
  • [43] Extramedullary Blast Crisis in a Patient with T315I BCR-ABL Mutated Chronic Myeloid Leukemia
    Zhang, Jingwen
    Zhang, Xiangzhong
    Lu, Ying
    Jiao, Ju
    Chen, Yuxin
    Lin, Dongjun
    CLINICAL LABORATORY, 2018, 64 (1-2) : 193 - 196
  • [44] Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR-ABL mutation
    Gotoh, Moritaka
    Tauchi, Tetsuzo
    Yoshizawa, Seiichiro
    Kitahara, Toshihiko
    Kiguchi, Toru
    Kimura, Yukihiko
    Ohyashiki, Kazuma
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (01) : 128 - 131
  • [45] ADDITIONAL C-ABL/BCR REARRANGEMENTS IN A CML PATIENT EXHIBITING 2 PH1-CHROMOSOMES DURING BLAST CRISIS
    BARTRAM, CR
    DEKLEIN, A
    HAGEMEIJER, A
    CARBONELL, F
    KLEIHAUER, E
    GROSVELD, G
    LEUKEMIA RESEARCH, 1986, 10 (02) : 221 - 225
  • [46] e8a2 BCR-ABL: more frequent than other atypical BCR-ABL variants?
    Demehri, S
    Paschka, P
    Schultheis, B
    Lange, T
    Koizumi, T
    Sugimoto, T
    Branford, S
    Lim, LC
    Kegel, T
    Martinelli, G
    Hochhaus, A
    Drucker, BJ
    Deininger, MWN
    LEUKEMIA, 2005, 19 (04) : 681 - 684
  • [47] Y253H mutation appearing in a μ-BCR-ABL (e19a2) CML
    Popovici, Cornel
    Charbonnier, Aude
    Gisserot, Olivier
    Aguilon, Philippe
    Remy, Virginie
    Olschwang, Sylviane
    Mozziconacci, Marie-Joelle
    LEUKEMIA RESEARCH, 2008, 32 (02) : 361 - 362
  • [48] BCR/ABL amplification in CML blast crisis following STI571 administration.
    Campbell, LJ
    Patsouris, C
    Rayeroux, KC
    Somana, K
    Januszewicz, H
    BLOOD, 2001, 98 (11) : 185B - 185B
  • [49] Application of a GM-CSF/BCR-ABL fusion molecule to a specific immunotherapy of CML.
    Setoyama, M
    Tojo, A
    Tani, K
    Asano, S
    BLOOD, 1998, 92 (10) : 386B - 386B
  • [50] Second case of CML with aberrant BCR-ABL fusion transcript (e8/a2) with insertion of an inverted ABL intron 1b sequence
    Sugimoto, T
    Ijima, K
    Hisatomi, H
    Murayama, T
    Mizuno, I
    Hato, A
    Imoto, S
    Nishimura, R
    Koizumi, T
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 77 (02) : 164 - 166
12345